I. Carter

发表

Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations

A. Green, A. Bench, N. Cross, 2013, British journal of haematology.

Simplified Hepatitis C Virus Genotyping by Heteroduplex Mobility Analysis

I. Carter, P. White, W. Rawlinson, 2000, Journal of Clinical Microbiology.

Metallo β Lactamases Gene blaimp, blaspm and blavim Detection by Multiplex Real-Time TaqMan Assay on the Smartcycler

I. Carter, 2010 .

A cluster of culture positive gonococcal infections but with false negative cppB gene based PCR

S. Garland, I. Carter, S. Tabrizi, 2005, Sexually Transmitted Infections.

Real-time PCR for laboratory diagnosis of Acanthamoeba keratitis

I. Carter, P. Taylor, Liping Wang, 2011 .

PCR Methodology

I. Carter, T. Sloots, P. Giffard, 2010, PCR for Clinical Microbiology.

PCR for clinical microbiology: An Australian and international perspective

Gregory James, I. Carter, T. Sloots, 2010 .

Single-center Series of Bone Marrow Biopsy-Defined Large Granular Lymphocyte Leukemia: High Rates of Sustained Response to Oral Methotrexate.

I. Carter, A. Haynes, T. Munir, 2016, Clinical lymphoma, myeloma & leukemia.

Evaluation of a worldwide EQA scheme for complex clonality analysis of clinical lymphoproliferative cases demonstrates a learning effect

D. Lenze, C. Keppens, E. Dequeker, 2021, Virchows Archiv.

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma.

S. Barrans, G. Morgan, I. Carter, 2002, Blood.